Heart Drug Shows Promise in Fighting Deadly Ovarian Cancer
30 Jan 2025
Ovarian cancer remains one of the most deadly cancers globally, with high-grade serous ovarian cancer (HGSOC) being the most common and lethal subtype. Despite the ongoing advancements in cancer research, current treatment options for HGSOC are limited, with most therapies failing to prevent recurrence. Researchers at the University of Pennsylvania’s...
Read More
